These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 12124824

  • 1. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W, Ikeda H, Yoshimoto T.
    Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824
    [Abstract] [Full Text] [Related]

  • 2. [Clinicopathology, clonality, and hormone production profile of prolactinoma].
    Ma WB, Ikeda H, Yoshimoto T.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 01; 85(20):1382-7. PubMed ID: 16029648
    [Abstract] [Full Text] [Related]

  • 3. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
    Talan-Hranilović J, Gnjidić Z, Sajko T, Vizner B, Vrkljan M.
    Acta Med Croatica; 2000 Jun 01; 54(2):59-63. PubMed ID: 11028110
    [Abstract] [Full Text] [Related]

  • 4. Gender-related differences in prolactin secretion in pituitary prolactinomas.
    Nishioka H, Haraoka J, Akada K, Azuma S.
    Neuroradiology; 2002 May 01; 44(5):407-10. PubMed ID: 12012125
    [Abstract] [Full Text] [Related]

  • 5. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A, Groupe d'études des Tumeurs Endocrines.
    Am J Surg Pathol; 2008 Apr 01; 32(4):534-43. PubMed ID: 18300794
    [Abstract] [Full Text] [Related]

  • 6. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N, Turner HE, Wass JA.
    Clin Endocrinol (Oxf); 2006 Oct 01; 65(4):524-9. PubMed ID: 16984247
    [Abstract] [Full Text] [Related]

  • 7. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J, Sáez L, Lemp M, Liberman C, Michelsen H, Araya AV.
    Rev Med Chil; 2008 Jul 01; 136(7):831-6. PubMed ID: 18949157
    [Abstract] [Full Text] [Related]

  • 8. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E, Sassolas G, Perrin G, Jan M, Trouillas J.
    Acta Neurochir (Wien); 2005 Jul 01; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [Abstract] [Full Text] [Related]

  • 9. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH, Figueroa CD, Smith CM, Bhoola KD.
    Agents Actions Suppl; 1992 Jul 01; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
    Umeoka K, Sanno N, Oyama K, Tahara S, Kurotani R, Ikuyama S, Nakashima M, Watanabe T, Osamura RY, Teramoto A.
    Mod Pathol; 2001 Dec 01; 14(12):1232-6. PubMed ID: 11743045
    [Abstract] [Full Text] [Related]

  • 11. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmüller D.
    Acta Neurochir (Wien); 2002 Jun 01; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
    Cap J, Marekova M, Cerman J, Malirova E, Suba P, Netuka D, Hana V, Marek J.
    Gen Physiol Biophys; 2003 Jun 01; 22(2):201-12. PubMed ID: 14661732
    [Abstract] [Full Text] [Related]

  • 13. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I, Bácsy E, Varga I, Slowik F, Bálint K, Pásztor E, Czirják S, Gláz E.
    Folia Histochem Cytobiol; 2000 Jun 01; 38(3):119-27. PubMed ID: 10970071
    [Abstract] [Full Text] [Related]

  • 14. Pituitary adenomas: immunohistochemical: study of 90 cases.
    Kasantikul V, Shuangshoti S.
    J Med Assoc Thai; 1990 Sep 01; 73(9):514-21. PubMed ID: 2262756
    [Abstract] [Full Text] [Related]

  • 15. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G, Traish D, Ashley S, Gonsalves A, Brada M.
    Clin Endocrinol (Oxf); 2006 May 01; 64(5):542-8. PubMed ID: 16649974
    [Abstract] [Full Text] [Related]

  • 16. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D.
    Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350
    [Abstract] [Full Text] [Related]

  • 17. Plurihormonal pituitary adenomas.
    Scheithauer BW, Horvath E, Kovacs K, Laws ER, Randall RV, Ryan N.
    Semin Diagn Pathol; 1986 Feb 12; 3(1):69-82. PubMed ID: 3039632
    [Abstract] [Full Text] [Related]

  • 18. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I, Hinton DR, Weiss MH, Melmed S.
    Clin Endocrinol (Oxf); 1998 Jan 12; 48(1):23-9. PubMed ID: 9509064
    [Abstract] [Full Text] [Related]

  • 19. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E, Kovacs K.
    Am J Pathol; 1989 Mar 12; 134(3):605-13. PubMed ID: 2466405
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
    Trouillas J, Girod C, Claustrat B, Joly-Pharaboz MO, Chevallier P.
    Cancer Res; 1990 Jul 01; 50(13):4081-6. PubMed ID: 2354457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.